From A.J. Lanigan's book: Health in a Pill and Other Medical Myths

To contact author write:
A.J.Lanigan
P.O. Box 6337
Columbia S.C. 29260

URL:http://www.clynx.com/AJ/ajsbook.html

BACK TO BASICS

     Leading physicians and researchers have begun to use many of the
techniques previously described in this book. In a number of laboratories
and clinics, some of these doctors have gone back to the basics. They have
started accepting that the human body is the source of healing and not
some pill machine. Ideas discussed in the following pages are actually
being practiced on patients around the world with varying degrees of
success. Keep in mind that many patients that end up on these therapies
have alr eady run the gauntlet of orthodox treatment and have been told
that nothing more can be done. 

GONZALEZ VERIFIES KELLY PROGRAM
     Dr. Nicholas James Gonzalez, who practices in New York City, is using
an innovative nutritional protocol to successfully treat far advanced
cancer patients. As a classically trained immunologist, he approached this
therapy with a great deal of skepti cism but became convinced of its value
during an exhaustive five year research project. 
     In July of 1981, during the summer preceding his third year at
Cornell University Medical College, Dr. Gonzales embarked upon an informal
evaluation of a nutritional approach to cancer. A friend had asked him to
look into a dentist named Kelly in Texas who had reportedly cured a
patient of terminal cancer. What started as a way to spend a summer
vacation eventually developed into a five year research project under the
direction of the former President of Sloan Kettering Institute, Dr. Robert
Good. 
     On his trip to Texas, Gonzales was astonished to find case after
case, if appropriately diagnosed, of advanced metastatic cancer patients
who were healthy and active 5, 10, and 15 years after diagnosis. Kelly had
made available all of his records, we ll over 10,000 patients, and
encouraged Gonzales to contact any and all of them. 
     Gonzales returned to New York to ask for advise from Dr. Good whom he
had befriended when Good was President of Sloan Kettering and Gonzales was
a first year medical student. Good eventually served as faculty advisor as
the study evolved and extended to an independent research project during 
Gonzalez senior year. Though subsequently moving to the University of 
Oklahoma, Good continued under special arrangements as sponsor and guide. 
When Good became Chief of Pediatrics at All Children's Hospital at the 
University of South Florida, Gonzalez joined him to complete the project. 
Many of the patients under this study were examined by both Gonzalez and 
Good. 
     Dr. Good had suggested that as an initial goal, fifty terminal cancer
patients be identified who had done well on Kelly s nutritional protocol.
The patients were to have been diagnosed by the appropriate specialist so
that there could be no doubt about the diagnosis of cancer. 
     An initial review of all records between 1970 and 1982 yielded 1,306
patients. Contacting these patients by mail produced over 1000 potential
candidates for the study. At this point, lengthy phone interviews were
begun, essentially starting at the to p of the list and concluding until
enough patients (455) had been obtained to ensure that at least 50 that
would meet Dr. Good s strict inclusion criteria. 
      Median survival of this group of 50 patients, all of whom had
terminal or extremely poor prognosis, was 10 years as of the date of
study. 
     Eventually the group of 455 was reduced to 160 that fit Dr. Good s
inclusion criteria. For each of these cases, complete medical records were
obtained. Follow-up was extensive, including examination of patients,
interviews, with family and physicians , etc.. From these 160 cases, 50
representative cases were chosen and presented in a 300 page manuscript
detailing the study. Another 200+ pages, copies of medical records, were
included in this yet to be published document. 
     The fifty patients represented 25 different types of cancer. There
were 28 males and 22 females, ages 21-77 at the start of therapy and 33-83
at the time of the study. Patients were included from 24 states, and
occupations varied widely. Twenty five of these patients were diagnosed at
two or more medical centers. Twenty three were diagnosed at major
institutions such as the Mayo Clinic, Memorial Sloan-Kettering, M.D.
Anderson, etc. Forty eight cases provided biopsy confirmation of cancer,
the other t wo upon exploratory surgery, were found to have large
inoperable tumors where the attending surgeon thought that the diagnosis
was obvious and did not want to risk biopsy surgery. Median survival of
this group of 50 patients, all of which had terminal or extremely poor
prognosis, was 10 years as of the date of the study. 
     As extraordinary as these results were, Dr. Good thought a further
step was required. He wanted a numerator/denominator study. Dr. Gonzalez
was to pick one type of cancer, identify every patient seeing Kelley with
this diagnosis and follow up on all patients to establish a response rate. 
     Gonzalez chose pancreatic cancer, since the 5 year survival rate in
orthodox medicine is virtually 0%. All patients consulting Kelley between
1974 and 1982 were reviewed to produce 22 who had been diagnosed with
pancreatic cancer. The 22 broke down into three groups. Ten patients
consulted Kelley only once and never went on the protocol. All had died.
Seven patients followed the protocol only partially and sporadically, as
determined by interview with family members, physicians, and records
obtained from the manufacturer/distributor of the special nutritional
supplements. These patients had all died. Five patients followed the
protocol completely and achieved long-term remission, although one had
died (of Alzheimers) after 11.5 years survival. 
     The median survival of the three groups was as follows: 1. Never
follow (10) = 67 days 2. Followed partially (7) = 233 days 3. Followed
completely (5) = 9 years
     At this point, Dr. Good and Dr. Gonzalez realized that even though
Kelley s results were extraordinary, in fact unparalleled in medicine,
they were of little use in the treatment of cancer unless they could be
independently reproduced. This is the stage of the research at present.
Over the past years, Dr. Gonzalez has been using the Kelly protocol with a
few modifications of his own in the treatment of terminal cancer. TOTAL
COST OF THE PROGRAM IS ABOUT $5,000 TO $6,000 PER YEAR. 
     Dr. Gonzalez keeps careful records on his patients; and with Kelly no
longer practicing, he is monitoring many of Kelly s patients after 10
years or more. He is finding that about 80% of the people are doing well
on his therapy. Most of his patients have been heavily pretreated by
orthodox means (surgery, radiation, chemotherapy) and, have failed these,
have come to him with a prognosis of two or three months to live. 
     One of the attractive points of his therapy is the cost. After about
2 years a maintenance program is used at a further reduced cost.
Supplements constitute about 70% to 80% of the cost. There is generally no
hospital cost involved. This is perhaps only 10% of the cost one might
expect to pay as a terminally ill cancer patient. 
     At the conclusion of his manuscript, Dr. Gonzalez stated that his
hope was to have this particular nutritional therapy evaluated further
under controlled clinical conditions in an academic setting. This has not
happened. The approach is so unorthodox that although a number of doctors 
in academic medicine now refer patients to Dr. Gonzalez, no one is 
stepping forward to fund a clinical trial. The protocol, briefly 
described, consists of six basic components: 1. Appropriate diet - there 
are 10 basic diets with 94 variations ranging from strict vegetarian to 
red meat depending on the cancer and the patient. 2. Intensive 
nutritional support - depending on each patient's deficiencies, vitamins, 
minerals, trace elements, electrolytes, and amino acids are described. 3. 
Protomorphgen support - these are concentrates in pill form, of raw beef 
organs and glands. 4. Digestive aids - e.g., pepsin, hydrochloric acid, 
etc. 5. Pancreatic enzyme therapy - proteolytic pancreatic enzymes are 
taken orally to attack and liquefy tumors.  6. Detoxification - among the 
many regimens used is the coffee enema. The purpose is to help the body 
eliminate the unnatural abundance of toxins and waste products as tumors 
break down in the body. 

[........ see beard-a.txt ......]

NCI Sponsors Clinical Trial to Evaluate Program

     The National Cancer Institute will evaluate alternative methods that
have met the "best-case-series standards" (Contact Mary McCabe, RN, a
clinical trials specialist for NCI at 301-496-5583 for questions).  The
Kelley Program, developed by William Donald Kelley, DDS was used to heal
his own pancreatic cancer in 1967.  In a 17 year period, over 10,000
seriously ill patients were treated with this program.  Many were
terminally ill cancer patients, some still surviving as of this date. 
Nicholas Gonzales, MD, who conducted an exhaustive 5 year study of
Kelley's program, will conduct an initial 10 case pancreatic cancer trial. 
This is the subject of the NCI's interest.  Dr. Gonzales is presently
practicing his version of the Kelley method in New York.  The phone 
number I have for him is 212-213-3337.